KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zimmer Biomet Holdings (ZBH) Capital Expenditures (2016 - 2025)

Zimmer Biomet Holdings (ZBH) has 17 years of Capital Expenditures data on record, last reported at $74.8 million in Q4 2025.

  • For Q4 2025, Capital Expenditures rose 45.24% year-over-year to $74.8 million; the TTM value through Dec 2025 reached $224.5 million, up 10.16%, while the annual FY2025 figure was $224.5 million, 10.16% up from the prior year.
  • Capital Expenditures reached $74.8 million in Q4 2025 per ZBH's latest filing, up from $55.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $97.3 million in Q2 2023 and bottomed at $24.6 million in Q2 2021.
  • Average Capital Expenditures over 5 years is $52.5 million, with a median of $49.6 million recorded in 2021.
  • Peak YoY movement for Capital Expenditures: skyrocketed 137.9% in 2023, then tumbled 47.21% in 2024.
  • A 5-year view of Capital Expenditures shows it stood at $49.2 million in 2021, then grew by 28.86% to $63.4 million in 2022, then fell by 0.95% to $62.8 million in 2023, then decreased by 17.99% to $51.5 million in 2024, then soared by 45.24% to $74.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Capital Expenditures were $74.8 million in Q4 2025, $55.0 million in Q3 2025, and $50.1 million in Q2 2025.